Literature DB >> 35941418

The secretome obtained under hypoxic preconditioning from human adipose-derived stem cells exerts promoted anti-apoptotic potentials through upregulated autophagic process.

Haeyeon Seo1,2, Ho Joong Choi1, Ok-Hee Kim1,2, Jung Hyun Park2,3, Ha Eun Hong1,2, Say-June Kim4,5,6.   

Abstract

BACKGROUND: Hypoxic preconditioning (HP) is a stem cell preconditioning modality designed to augment the therapeutic effects of mesenchymal stem cells (MSCs). Although autophagy is expected to play a role in HP, very little is known regarding the relationship between HP and autophagy. METHODS AND
RESULTS: The adipose-derived stem cell (ASC)-secretome obtained under normoxia (NCM) and ASC-secretome obtained under HP (HCM) were obtained by culturing ASCs for 24 h under normoxic (21% partial pressure of O2) and hypoxic (1% partial pressure of O2) conditions, respectively. Subsequently, to determine the in vivo effects of HCM, each secretome was injected into 70% partially hepatectomized mice, and liver specimens were obtained. HCM significantly reduced the apoptosis of thioacetamide-treated AML12 hepatocytes and promoted the autophagic processes of the cells (P < 0.05). Autophagy blockage by either bafilomycin A1 or ATG5 siRNA significantly abrogated the anti-apoptotic effect of HCM (P < 0.05), demonstrating that HCM exerts its anti-apoptotic effect by promoting autophagy. The effect of HCM - reduction of cell apoptosis and promotion of autophagic process - was also demonstrated in a mouse model.
CONCLUSIONS: HP appears to induce ASCs to release a secretome with enhanced anti-apoptotic effects by promoting the autophagic process of ASCs.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Adipose-derived stem cell; Apoptosis; Autophagy; Hypoxic preconditioning; Liver injury; Secretome

Mesh:

Year:  2022        PMID: 35941418     DOI: 10.1007/s11033-022-07736-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  35 in total

Review 1.  Posthepatectomy liver failure.

Authors:  Teresa Schreckenbach; Juliane Liese; Wolf O Bechstein; Christian Moench
Journal:  Dig Surg       Date:  2012-03-15       Impact factor: 2.588

Review 2.  Uncovering the secretes of mesenchymal stem cells.

Authors:  Jessie R Lavoie; Michael Rosu-Myles
Journal:  Biochimie       Date:  2013-06-28       Impact factor: 4.079

3.  Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science.

Authors:  Lucian Beer; Michael Mildner; Hendrik Jan Ankersmit
Journal:  Ann Transl Med       Date:  2017-04

Review 4.  Mesenchymal stem cells: characteristics and clinical applications.

Authors:  Sylwia Bobis; Danuta Jarocha; Marcin Majka
Journal:  Folia Histochem Cytobiol       Date:  2006       Impact factor: 1.698

5.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

6.  Risk factors of liver failure after right-sided hepatectomy.

Authors:  Teijiro Hirashita; Masayuki Ohta; Yukio Iwashita; Kentaro Iwaki; Hiroki Uchida; Kazuhiro Yada; Toshifumi Matsumoto; Seigo Kitano
Journal:  Am J Surg       Date:  2013-07-05       Impact factor: 2.565

7.  Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

Authors:  Masako Miura; Yasuo Miura; Hesed M Padilla-Nash; Alfredo A Molinolo; Baojin Fu; Vyomesh Patel; Byoung-Moo Seo; Wataru Sonoyama; Jenny J Zheng; Carl C Baker; Wanjun Chen; Thomas Ried; Songtao Shi
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

8.  Sarcoma derived from cultured mesenchymal stem cells.

Authors:  Jakub Tolar; Alma J Nauta; Mark J Osborn; Angela Panoskaltsis Mortari; Ron T McElmurry; Scott Bell; Lily Xia; Ning Zhou; Megan Riddle; Tania M Schroeder; Jennifer J Westendorf; R Scott McIvor; Pancras C W Hogendoorn; Karoly Szuhai; Leann Oseth; Betsy Hirsch; Stephen R Yant; Mark A Kay; Alexandra Peister; Darwin J Prockop; Willem E Fibbe; Bruce R Blazar
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

9.  Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy.

Authors:  Serena Rubina Baglio; D Michiel Pegtel; Nicola Baldini
Journal:  Front Physiol       Date:  2012-09-06       Impact factor: 4.566

Review 10.  A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.

Authors:  Marialaura Madrigal; Kosagisharaf S Rao; Neil H Riordan
Journal:  J Transl Med       Date:  2014-10-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.